Back to Startup Insights
Castle Biosciences
Offers molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers.
Headquarters
United States
Year Founded
2018
Founders
Not specified
Country
United States
Financial Information
Funding Stage
Growth Stage
Recent Funding
-
Funding By
Venture Investors
Core Technology
Genomic profiling
Product Type
Diagnostic
Pipeline Stage (Very Important)
Commercialized
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: FDA Approved
- Clinical Trial Registration: N/A
- Patents / IP Status: Granted
Partnerships
Pharma Collaborations
Multiple
Academic / Hospital Tie-ups
Major US Cancer Centers
CRO/CDMO Partnerships
Established
Market & Differentiation
Comprehensive skin cancer genomics